StockData
XORTX Therapeutics Inc. logo

XORTX Therapeutics Inc. (XRTX) stock

XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 0/30
$1.06+0.02 (+1.92%)

Close on Nov 17, 2026Market cap $116.17KP/E –Yield –

XORTX Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

XORTX Therapeutics's price to book ratio was 34.6× on Feb 28, 2023, against 77.1× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Feb 28, 202334.6×−12.6
2022Dec 30, 202247.2×–

More XORTX Therapeutics figures

See a number that looks wrong?